Baykan, O. Et Al. 2019. The Relationship between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms. CLINICAL LABORATORY , vol.65 , 445-452.

Baykan, O., Akgul, M., Üren, N., Yaman, A., Tinay, İ., Ergül, E., ... Sazcı, A.(2019). The Relationship between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms. CLINICAL LABORATORY , vol.65, 445-452.

Baykan, Ozgur Et Al. "The Relationship between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms," CLINICAL LABORATORY , vol.65, 445-452, 2019

Baykan, Ozgur Et Al. "The Relationship between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms." CLINICAL LABORATORY , vol.65, pp.445-452, 2019

Baykan, O. Et Al. (2019) . "The Relationship between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms." CLINICAL LABORATORY , vol.65, pp.445-452.

@article{article, author={Ozgur Baykan Et Al. }, title={The Relationship between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms}, journal={CLINICAL LABORATORY}, year=2019, pages={445-452} }